Table 1

The overall and subgroup of selected variables among PUD patients in different seasons

OverallSpringSummerFallWinterP value
Overall13 0223317 (25.47)3143 (24.14)3072 (23.59)3490 (26.8)
Gender
 Male8392 (64.44)2146 (25.57)2035 (24.25)1959 (23.34)2252 (26.84)0.8391
 Female4630 (35.56)1171 (25.29)1108 (23.93)1113 (24.04)1238 (26.74)
Age
 <655273 (40.49)1342 (25.45)1299 (24.63)1250 (23.71)1382 (26.21)0.5473
 ≥657749 (59.51)1975 (25.49)1844 (23.8)1822 (23.51)2108 (27.2)
PUD type
 GU7306 (56.11)1822 (24.94)1814 (24.83)1750 (23.95)1920 (26.28)0.0816
 DU4720 (36.25)1256 (26.61)1090 (23.09)1078 (22.84)1296 (27.46)
 Others996 (7.65)239(24)239(24)244 (24.5)274 (27.51)
Area
 North4953 (38.04)1269 (25.62)1175 (23.72)1159 (23.4)1350 (27.26)0.6972
 Central3244 (24.91)825 (25.43)791 (24.38)792 (24.41)836 (25.77)
 South4292 (32.96)1086 (25.3)1056 (24.6)1010 (23.53)1140 (26.56)
 East472 (3.62)121 (25.64)107 (22.67)99 (20.97)145 (30.72)
 Others61 (0.47)16 (26.23)14 (22.95)12 (19.67)19 (31.15)
NSAIDs use
 Non-NSAIDs users4065 (31.22)1049 (25.81)941 (23.15)909 (22.36)1166 (28.68)0.0194
 NSAIDs users (non-long term)5111 (39.25)1304 (25.51)1239 (24.24)1242 (24.3)1326 (25.94)
 NSAIDs users (long term)3846 (29.53)964 (25.07)963 (25.04)921 (23.95)998 (25.95)
  • DU, duodenal ulcer; GU, gastric ulcer; NSAIDs, non-steroidal anti-inflammatory drugs; PUD, peptic ulcer disease.